586 related articles for article (PubMed ID: 15834457)
1. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents.
Adachi K; Hasegawa M; Fujita S; Sato M; Miwa Y; Ikeda H; Koshikawa N; Cools AR
Eur J Pharmacol; 2002 May; 442(1-2):81-92. PubMed ID: 12020685
[TBL] [Abstract][Full Text] [Related]
3. Role of GABA(A) receptors in the retrorubral field and ventral pallidum in rat jaw movements elicited by dopaminergic stimulation of the nucleus accumbens shell.
Uchida T; Adachi K; Fujita S; Lee J; Gionhaku N; Cools AR; Koshikawa N
Eur J Pharmacol; 2005 Mar; 510(1-2):39-47. PubMed ID: 15740723
[TBL] [Abstract][Full Text] [Related]
4. Involvement of NMDA receptors in the ventrolateral striatum of rats in apomorphine-induced jaw movements.
Fujita S; Kiguchi M; Kobayashi M; Koshikawa N; Waddington JL
Brain Res; 2010 Mar; 1322():30-7. PubMed ID: 20122906
[TBL] [Abstract][Full Text] [Related]
5. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors.
Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K
Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029
[TBL] [Abstract][Full Text] [Related]
6. The superior colliculus contains a discrete region involved in the control of jaw movements: role of GABAA receptors.
Adachi K; Hasegawa M; Ikeda H; Sato M; Koshikawa N; Cools AR
Eur J Pharmacol; 2003 Mar; 464(2-3):147-54. PubMed ID: 12620507
[TBL] [Abstract][Full Text] [Related]
7. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
McPherson RJ; Marshall JF
Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
[TBL] [Abstract][Full Text] [Related]
8. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons.
Martin LP; Waszczak BL
Brain Res; 1996 Aug; 729(2):156-69. PubMed ID: 8876984
[TBL] [Abstract][Full Text] [Related]
10. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.
Mayorga AJ; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
Psychopharmacology (Berl); 1999 Mar; 143(1):72-81. PubMed ID: 10227082
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
Zahr NM; Martin LP; Waszczak BL
Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
[TBL] [Abstract][Full Text] [Related]
13. NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation.
Kreipke CW; Walker PD
Synapse; 2004 Jul; 53(1):28-35. PubMed ID: 15150738
[TBL] [Abstract][Full Text] [Related]
14. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
15. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
Criswell HE; Johnson KB; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
[TBL] [Abstract][Full Text] [Related]
16. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
[TBL] [Abstract][Full Text] [Related]
17. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.
Kobayashi S; Ogren SO; Hoffer BJ; Olson L
Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169
[TBL] [Abstract][Full Text] [Related]
19. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
[TBL] [Abstract][Full Text] [Related]
20. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
Wedzony K; Czyrak A; Maćkowiak M; Fijał K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]